NCT07572279Not yet recruiting
Home Monitor for AA Burden Detection IIT in TWN
The Clinical Follow-Up of the Amvia Pacemaker Family Using Atrial Anti-Tachycardia Pacing (aATP) and Home Monitoring Function in the Patients With Paroxysmal Atrial Fibrillation (PAF)
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
Primary Endpoint: * Early detection rate in Atrial Arrhythmia (AA) burden * Data transmission success rate for overall number of atrial burden collection during the monitoring period Secondary Endpoints: * Atrial burden occurrence at 3/6/12 months post-aATP * Incidence of arrhythmia * Safety: Immediate (\< 24 hours), in-hospital, 3 months, 6 months and 12 months adverse events
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 28 Apr 2026
- Start date
- 1 Dec 2026
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- National Taiwan University Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT07572279
What you commit to
- Study type: Observational
- Planned participants: 30
- From 1 Dec 2026 to the primary completion date, 31 Dec 2030
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in another prospective interventional clinical study within a period of 4 weeks prior to the implantation of Atrial Arrhythmia
Other illness
- Abnormal baseline findings considered by the investigator to indicate conditions that might affect study endpoints
- Present or history of drug addiction
- Any other condition that, in the investigator's judgment, might increase the risk to the patients or affect trial quality
Other
- Patients are not able to use CardioMessenger 4G or its successors
- Life expectancy \< 1 year
- Sepsis
- Long-standing Persistent Atrial Fibrillation or Permanent Atrial Fibrillation
- Pregnant or breast-feeding women
- Patients underwent implantable cardioverter-defibrillator implantation
Who the study is looking for
- Adult patients ≥ 20 years of age
- Diagnosed with Paroxysmal Atrial Fibrillation (PAF) or atrial flutter who have been implanted or planned to implant with permanent pacemaker device
- The diagnosis of AF is confirmed on a 12-lead electrocardiogram (ECG) or lasting \>30 seconds in single lead ECG monitor
- Implanted within 12 weeks prior to enrollment or being considered for implantation of a PPM with Home Monitoring technology
- Able to give informed consent for the participation in the trial
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospital Hsin Chu Branch Coordinator of this site? Confirm its status | Hsinchu | Taiwan | Unknown status |
| National Taiwan University Hospita Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
| Cathay General Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
| MacKay Memorial Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.